All Stories

  1. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect

    Article • Parasitology Research, August 2020, Springer Science + Business Media

    Dr Neeloo Singh

  2. Recombinant Leishmania Rab6 (rLdRab6) is recognized by sera from visceral leishmaniasis patients

    Article • Experimental Parasitology, September 2016, Elsevier

    Dr Neeloo Singh

  3. Evolutionary comparison of prenylation pathway in kinetoplastid Leishmania and its sister Leptomonas

    Article • BMC Evolutionary Biology, November 2015, Springer Science + Business Media

    Dr Neeloo Singh

  4. Green Synthesis of Silver and Titanium Dioxide Nanoparticles Using Euphorbia prostrata Extract Shows Shift from Apoptosis to G0/G1Arrest followed by Necrotic Cell Death in Leishmania donovani

    Article • Antimicrobial Agents and Chemotherapy, June 2015, ASM Journals

    Dr Neeloo Singh

  5. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India

    Article • Parasites & Vectors, December 2014, Springer Science + Business Media

    Dr Neeloo Singh

  6. SOLiD™ Sequencing of Genomes of Clinical Isolates of Leishmania donovani from India Confirm Leptomonas Co-Infection and Raise Some Key Questions

    Article • PLoS ONE, February 2013, PLOS

    Dr Surendra K Chikara, Dr Neeloo Singh

  7. Bioinformatic Analysis ofLeishmania donovaniLong-Chain Fatty Acid-CoA Ligase as a Novel Drug Target

    Article • Molecular Biology International, January 2011, Hindawi Publishing Corporation

    Dr Neeloo Singh

  8. Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates

    Article • Molecular and Biochemical Parasitology, October 2010, Elsevier

    Professor Alan H Fairlamb, Dr Neeloo Singh

  9. Leishmania donovani: Oral therapy with glycosyl 1,4-dihydropyridine analogue showing apoptosis like phenotypes targeting pteridine reductase 1 in intracellular amastigotes

    Article • Experimental Parasitology, July 2010, Elsevier

    Dr Neeloo Singh

  10. Leishmania donovani: A glycosyl dihydropyridine analogue induces apoptosis like cell death via targeting pteridine reductase 1 in promastigotes

    Article • Experimental Parasitology, November 2009, Elsevier

    Dr Neeloo Singh

  11. Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate

    Article • Experimental Parasitology, August 2009, Elsevier

    Dr Neeloo Singh

  12. An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1

    Article • Parasitology Research, July 2009, Springer Science + Business Media

    Dr Neeloo Singh

  13. Discovery of Novel Vaccine Candidates and Drug Targets Against Visceral Leishmaniasis Using Proteomics and Transcriptomics

    Article • Current Drug Targets, November 2008, Bentham Science Publishers

    Dr Neeloo Singh

  14. Leishmania donovani pteridine reductase 1: Biochemical properties and structure-modeling studies

    Article • Experimental Parasitology, September 2008, Elsevier

    Dr Neeloo Singh

  15. Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis

    Article • PROTEOMICS - CLINICAL APPLICATIONS, February 2008, Wiley

    Dr Neeloo Singh

  16. Degradation of pteridine reductase 1 (PTR1) enzyme during growth phase in the protozoan parasite Leishmania donovani

    Article • Experimental Parasitology, June 2007, Elsevier

    Dr Neeloo Singh

  17. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani

    Article • Parasitology International, March 2007, Elsevier

    Dr Neeloo Singh

  18. Translation of open reading frame in kinetoplast DNA minicircles of clinical isolates of L. donovani

    Article • Parasitology Research, October 2006, Springer Science + Business Media

    Dr Neeloo Singh

  19. Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate

    Article • Protein Expression and Purification, January 2006, Elsevier

    Dr Neeloo Singh

  20. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models

    Article • Parasitology Research, May 2005, Springer Science + Business Media

    Dr Neeloo Singh

  21. Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani

    Article • Protein Expression and Purification, December 2004, Elsevier

    Dr Neeloo Singh

  22. Novel Mechanism of Drug Resistance in Kala Azar Field Isolates

    Article • The Journal of Infectious Diseases, August 2003, Oxford University Press (OUP)

    Dr Neeloo Singh

  23. Characterization of kinetoplast DNA minicircles of an Indian isolate of Leishmania donovani

    Article • Acta Tropica, October 1999, Elsevier

    Dr Neeloo Singh

  24. Diagnostic PCR withLeishmania donovanispecificity using sequences from the variable region of kinetoplast minicircle DNA

    Article • Tropical Medicine & International Health, June 1999, Wiley

    Dr Neeloo Singh

  25. Kinetoplast DNA minicircles of Leishmania donovani express a protein product

    Article • Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, February 1999, Elsevier

    Dr Neeloo Singh

  26. Reply to V.S. Sloan

    Article • September 1997, Centers for Disease Control and Prevention (CDC)

    Dr Neeloo Singh

  27. Molecular typing of HLA class I and class II antigens in Indian kala-azar patients

    Article • Tropical Medicine & International Health, May 1997, Wiley

    Dr Neeloo Singh

  28. Molecular typing of HLA class I and class II antigens in Indian kala-azar patients

    Article • Tropical Medicine & International Health, May 1997, Wiley

    Dr Neeloo Singh

  29. Infectious Diseases and Immunity: Special Reference to Major Histocompatibility Complex

    Article • March 1997, Centers for Disease Control and Prevention (CDC)

    Dr Neeloo Singh

  30. Molecular typing of HLA class II DR antigens in indian kala azar patients

    Article • Human Immunology, April 1996, Elsevier

    Dr Neeloo Singh

  31. Antibodies to Lactate Dehydrogenase ofPlasmodium Knowlesiare Specific toPlasmodiumSpecies

    Article • Immunological Investigations, January 1988, Taylor & Francis

    Dr Neeloo Singh